DIMENSIONAL FUND ADVISORS LP - JOUNCE THERAPEUTICS INC ownership

JOUNCE THERAPEUTICS INC's ticker is JNCE and the CUSIP is 481116101. A total of 106 filers reported holding JOUNCE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.23 and the average weighting 0.5%.

Quarter-by-quarter ownership
DIMENSIONAL FUND ADVISORS LP ownership history of JOUNCE THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$488,900
+61552.0%
264,270
-63.0%
0.00%
Q4 2022$793
-100.0%
715,037
-29.0%
0.00%
-100.0%
Q3 2022$2,355,000
-34.6%
1,006,646
-15.3%
0.00%0.0%
Q2 2022$3,599,000
-55.1%
1,187,801
+0.7%
0.00%
-50.0%
Q1 2022$8,012,000
-14.2%
1,179,953
+5.5%
0.00%
-33.3%
Q4 2021$9,341,000
+20.0%
1,118,701
+6.8%
0.00%0.0%
Q3 2021$7,783,000
-6.7%
1,047,545
-14.6%
0.00%0.0%
Q2 2021$8,345,000
-23.4%
1,227,280
+15.7%
0.00%
-25.0%
Q1 2021$10,890,000
+32.2%
1,060,431
-9.9%
0.00%
+33.3%
Q4 2020$8,239,000
-15.1%
1,177,073
-1.0%
0.00%
-25.0%
Q3 2020$9,702,000
+22.7%
1,188,967
+3.8%
0.00%
+33.3%
Q2 2020$7,904,000
+54.9%
1,145,370
+6.6%
0.00%0.0%
Q1 2020$5,103,000
-31.6%
1,074,216
+25.7%
0.00%0.0%
Q4 2019$7,460,000
+175.6%
854,606
+5.1%
0.00%
+200.0%
Q3 2019$2,707,000
-29.6%
812,828
+4.6%
0.00%0.0%
Q2 2019$3,847,000
-3.9%
777,264
+20.3%
0.00%
-50.0%
Q1 2019$4,005,000
+160.1%
646,000
+41.4%
0.00%
+100.0%
Q4 2018$1,540,000
-45.4%
456,865
+5.3%
0.00%0.0%
Q3 2018$2,819,000
+16.9%
433,712
+37.8%
0.00%0.0%
Q2 2018$2,412,000
-2.0%
314,831
+186.0%
0.00%0.0%
Q1 2018$2,460,000110,0690.00%
Other shareholders
JOUNCE THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
TRV GP II, LLC 1,347,829$9,152,00093.42%
Ally Bridge Group (NY) LLC 550,000$3,735,0002.77%
ACUTA CAPITAL PARTNERS, LLC 813,500$5,524,0002.58%
TRV GP III, LLC 1,148,780$7,800,0002.12%
Deep Track Capital, LP 4,259,653$28,923,0001.86%
Logos Global Management LP 1,400,000$9,506,0001.23%
PFM Health Sciences, LP 3,972,868$26,976,0001.01%
Sofinnova Investments, Inc. 1,481,219$10,057,0000.76%
SILVERARC CAPITAL MANAGEMENT, LLC 248,347$1,686,0000.70%
RTW INVESTMENTS, LP 4,680,412$31,780,0000.66%
View complete list of JOUNCE THERAPEUTICS INC shareholders